Q, Y., J, Y., M, M., Z, Z., C, P., Q, L., . . . Y, Q. (2026). Discovery of novel tumor-targeting peptide-oncolytic peptide based conjugates (PPCs): A new paradigm for targeted oncolytic-immunotherapy. Acta pharmaceutica Sinica. B, 16(7), 4491. https://doi.org/10.1016/j.apsb.2026.01.006
Chicago Style (17th ed.) CitationQ, Yu, et al. "Discovery of Novel Tumor-targeting Peptide-oncolytic Peptide Based Conjugates (PPCs): A New Paradigm for Targeted Oncolytic-immunotherapy." Acta Pharmaceutica Sinica. B 16, no. 7 (2026): 4491. https://doi.org/10.1016/j.apsb.2026.01.006.
MLA (9th ed.) CitationQ, Yu, et al. "Discovery of Novel Tumor-targeting Peptide-oncolytic Peptide Based Conjugates (PPCs): A New Paradigm for Targeted Oncolytic-immunotherapy." Acta Pharmaceutica Sinica. B, vol. 16, no. 7, 2026, p. 4491, https://doi.org/10.1016/j.apsb.2026.01.006.